MED
MEDIFAST INC
+0.13 (+1.09%)12.09USD32.0K成交股數135M市值–本益比(近四季)0.4股價營收比-27.6%營收年增(近四季)2026-11-09下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 76.4M-34% | 76.0M-36% | 89.4M-36% | 106M-37% | 116M-34% | 119M-50% | 140M-53% | 169M-52% | 175M | 236M | 296M | 349M |
| 營業成本 | 23.0M | 24.3M | 27.3M | 28.9M | 31.5M | 30.8M | 34.5M | 45.1M | 47.4M | 58.5M | 85.5M | 103M |
| 毛利 | 53.4M-37% | 51.8M-41% | 62.2M-41% | 76.6M-38% | 84.2M-34% | 88.2M-50% | 106M-50% | 123M-50% | 127M | 177M | 211M | 246M |
| 毛利率 | 69.9% | 68.1% | 69.5% | 72.6% | 72.8% | 74.1% | 75.4% | 73.2% | 72.8% | 75.2% | 71.1% | 70.6% |
| 研發費用 | – | – | – | – | – | – | – | – | – | – | – | – |
| 銷售管理費用 | 57.7M | 55.1M | 66.2M | 77.7M | 85.5M | 87.5M | 104M | 131M | 119M | 152M | 172M | 193M |
| 營業利益 | −4.3M+243% | −3.3M-565% | −4.1M-294% | −1.1M-86% | −1.3M-116% | 708K-97% | 2.1M-95% | −7.9M-115% | 7.9M | 25.5M | 38.7M | 53.5M |
| 營業利益率 | -5.7% | -4.3% | -4.6% | -1.0% | -1.1% | 0.6% | 1.5% | -4.7% | 4.5% | 10.8% | 13.1% | 15.3% |
| 稅後淨利 | −3.1M+302% | −2.1M-399% | −2.3M-300% | 2.5M-130% | −772K-109% | 709K-97% | 1.1M-96% | −8.2M-120% | 8.3M | 23.1M | 30.3M | 40.0M |
| 淨利率 | -4.1% | -2.8% | -2.5% | 2.3% | -0.7% | 0.6% | 0.8% | -4.8% | 4.8% | 9.8% | 10.2% | 11.5% |
| 稀釋 EPS | -0.28+300% | -0.19-338% | -0.21-310% | 0.22-129% | -0.07-109% | 0.08-96% | 0.10-96% | -0.75-120% | 0.76 | 2.12 | 2.77 | 3.67 |
| 稀釋股數 | 11.1M | 11.0M | 11.0M | 11.1M | 10.9M | 11.0M | 11.0M | 10.9M | 11.0M | 10.9M | 10.9M | 10.9M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 71.9M | 71.5M | 99.5M | 102M | 91.7M | 90.9M | 115M | 108M | 97.5M | 113M | 147M | 124M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | 21.2M | 21.4M | 23.2M | 30.2M | 39.4M | 42.4M | 40.1M | 39.6M | 46.3M | 58.2M | 68.9M | 96.9M |
| 總資產 | 260M | 252M | 268M | 269M | 280M | 284M | 291M | 294M | 303M | 320M | 319M | 322M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 64.0M | 54.4M | 53.5M | 53.3M | 69.1M | 74.1M | 83.9M | 88.2M | 91.8M | 127M | 133M | 151M |
| 股東權益 | 196M | 198M | 215M | 216M | 211M | 210M | 207M | 205M | 211M | 193M | 186M | 171M |
| 負債比 | 24.6% | 21.6% | 19.9% | 19.8% | 24.7% | 26.1% | 28.8% | 30.1% | 30.3% | 39.7% | 41.8% | 46.9% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 260K | – | – | 3.4M-53% | – | – | – | 7.3M | – | – | 64.1M |
| 資本支出 | – | 1.1M | – | – | 1.5M | – | – | – | 1.8M | – | – | 2.1M |
| 自由現金流 | – | −836K | – | – | 1.9M-65% | – | – | – | 5.4M | – | – | 61.9M |
| 折舊攤銷 | – | 3.5M | – | – | 3.3M | – | – | – | 3.3M | – | – | 3.0M |
| 買回庫藏股 | – | – | – | – | – | – | – | – | 0.00 | – | – | 3.6M |
| 現金股利 | – | 87K | – | – | 194K | – | – | – | 710K | – | – | 19.2M |
| 自由現金流率 | – | -1.1% | – | – | 1.6% | – | – | – | 3.1% | – | – | 17.7% |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 386M
| Optavia | 386M | 100.0% | -36.0% |
|---|
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 386M | -36.0% | −19.0M | -4.9% | -1.70 | 1.2M |
| FY2024 | 602M | -43.8% | 2.0M | 0.3% | 0.19 | 17.0M |
| FY2023 | 1.1B | -32.9% | 99.0M | 9.2% | 9.10 | 141M |
| FY2022 | 1.6B | +4.8% | 144M | 9.0% | 12.73 | 178M |
| FY2021 | 1.5B | +63.2% | 164M | 10.7% | 13.89 | 60.3M |
| FY2020 | 935M | +31.0% | 103M | 11.0% | 8.68 | 139M |
| FY2019 | 714M | +42.4% | 77.9M | 10.9% | 6.43 | 74.2M |
| FY2018 | 501M | – | 55.8M | 11.1% | 4.62 | 55.9M |